AFM
IH

Anson Funds Management’s iHuman IH Stock Holding History

Anson Funds Management’s Portfolio IH Stock Details IH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,259
Closed -$29.3K – 194
2022
Q4 		$29.3K Buy
+11,259
New +$22.9K ﹤0.01% 221

Other funds holding IH

APA
Arisaig Partners (Asia) Singapore $2.17M AUM 37.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Anson Funds Management's IH Position: Q1 2023 in Review

Anson Funds Management sold out of iHuman (IH) in Q1 2023, closing a stake of 11,259 shares — an estimated $29.3K sold.

Anson Funds Management first reported a position in IH in Q4 2022 and held it in 1 quarter. The position peaked at $29.3K in Q4 2022. 5 funds tracked by Wall St. Rank hold IH as of Q1 2023.

  • Anson Funds Management reported no remaining iHuman position as of Q1 2023 after selling out during the quarter.
  • Anson Funds Management sold 11,259 iHuman shares in Q1 2023, an estimated $29.3K.
  • Anson Funds Management first reported a position in iHuman in Q4 2022 and held it in 1 quarter.
  • Anson Funds Management's iHuman position peaked at $29.3K in Q4 2022.
  • 5 funds tracked by Wall St. Rank held iHuman as of Q1 2023.

Based on Anson Funds Management's 13F filing for Q1 2023, filed 15 May 2023.